Μετάβαση στο περιεχόμενο
WSU-DLCL2
Ιστός
Pleural effusion
Ασθένεια
Diffuse large B-cell lymphoma germinal center B-cell type
Συνώνυμα
WSU-DLCL-2, WSU-DLCL(2), WSUDLCL2

Έγγραφα

WSU-DLCL2

Cell line · Αριθμός προϊόντος 305655

Η WSU-DLCL2 είναι μια κυτταρική σειρά ανθρώπινου διάχυτου μεγάλου κυτταρικού Β-λεμφώματος (DLBCL) που έχει χρησιμοποιηθεί ευρέως στην έρευνα για το λέμφωμα. Αποτελεί μέρος αρκετών μεγάλης κλίμακας γενετικών...

€430.00χωρίς ΦΠΑ και έξοδα αποστολής

Προσαρμογή / Προτάσεις

Σε απόθεμα
Lot
Συνιστάται (η πιο φρέσκια παρτίδα)
  • CoA
1

01Γενικές πληροφορίες

Περιγραφή

WSU-DLCL2 is a human diffuse large B-cell lymphoma (DLBCL) cell line that has been widely used in lymphoma research. It is part of several large-scale genomic and proteomic characterization efforts, such as the Cancer Cell Line Encyclopedia (CCLE) and the LL-100 panel, which provide comprehensive molecular data for leukemia and lymphoma models. WSU-DLCL2 is classified within the germinal center B-cell (GCB) subtype of DLBCL and carries the EZH2 Y646F mutation, which is associated with altered histone methylation and epigenetic regulation of gene expression.

This cell line has been included in whole-genome sequencing studies to identify mutational landscapes in DLBCL, revealing a variety of structural alterations, somatic point mutations, and gene fusions. These genomic analyses have contributed to a better understanding of the oncogenic pathways involved in lymphomagenesis. Additionally, studies utilizing protein expression profiling, such as reverse-phase protein arrays, have demonstrated that WSU-DLCL2 exhibits distinct signaling pathway alterations that may influence drug sensitivity.

WSU-DLCL2 has also been studied in the context of antibody-dependent cellular cytotoxicity (ADCC) and resistance to targeted therapies, such as rituximab. Research has shown that the susceptibility of WSU-DLCL2 to rituximab-induced ADCC is influenced by the expression of CD20 and ligands for natural killer (NK) cell receptors, such as UL16-binding proteins (ULBP1-3). These findings support the use of WSU-DLCL2 as a preclinical model for evaluating novel therapeutic strategies targeting DLBCL.

Ιστός
Pleural effusion
Ασθένεια
Diffuse large B-cell lymphoma germinal center B-cell type
Συνώνυμα
  • WSU-DLCL-2
  • WSU-DLCL(2)
  • WSUDLCL2

02Ταξινόμηση

Οργανισμός
Άνθρωπος
Σεξ
Άνδρας
Ιδιότητες ανάπτυξης
Αναστολή
Επίπεδο βιοασφάλειας
1

03Χαρακτηριστικά

Μορφολογία
Round and oval cells growing singly or in small clumps
Χρόνος διπλασιασμού
18 hours, 40-60 hours

04Αναγνωριστικά

Παραπομπή
WSU-DLCL2 (Cytion catalog number 305655)
Αριθμός φορολογικού μητρώου NCBI
9606
Κελλοσαύρος
CVCL_1902

05Έκφραση και ευαισθησία

Έκφραση αντιγόνου
CD3 -, CD10 +, CD13 -, CD19 +, CD20 +, CD34 -, CD37 +, CD38 +, cyCD79a +, CD80 -, CD 138 -, HLA-DR +, sm/cyIgG +, sm/cyIgM -, sm/cykappa -, sm/cylambda +
Προφίλ μεταλλάξεων
Mutation: EZH2, Simple, p.Tyr646Phe (c.1937A>T) (Y641F), Heterozygous, TP53, Simple, p.Arg248Gln (c.743G>A), Homozygous
Ιοί
EBV -, HBV -, HCV -, HIV-1 -, HIV-2 -, HTLV-1/2 -, MLV -, SMRV -

06Χειρισμός και καλλιέργεια

Θρεπτικό μέσο
RPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Ατμόσφαιρα επώασης

37°C, 5% CO2, humidified atmosphere.

Συμπληρώματα
Supplement the medium with h.i.a. 10% FBS
Αναπαραγωγή σε υποκαλλιέργεια
0.5 x 106 cells/ml
Πυκνότητα σποράς
3-5*10^5/ml
Ανανέωση υγρών
2 to 3 times per week
Απόψυξη και καλλιέργεια
  1. Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit.

  2. Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required.

  3. For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains.

  4. Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening.

  5. Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently.

  6. Centrifuge the mixture at 300 x g for 3 minutes to separate the cells and carefully discard the supernatant containing residual freezing medium.

  7. Gently resuspend the cell pellet in 10 ml of fresh culture medium. For adherent cells, divide the suspension between two T25 culture flasks; for suspension cultures, transfer all the medium into one T25 flask to promote effective cell interaction and growth.

  8. Adhere to established subculture protocols for continued growth and maintenance of the cell line, ensuring reliable experimental outcomes.

07Έλεγχος ποιότητας και κρυοσυντήρηση

Στειρότητα

Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods.

To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections.

Μέσο κατάψυξης
As a cryopreservation medium, we recommend CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress.
Συνθήκες αποθήκευσης

For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen.

Όροι αποστολής

Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage.

08Δωρητής

Ηλικία δωρητή
41 years
Εθνικότητα
Caucasian

10Λεπτομέρειες προϊόντος

Πίνακας σύνθεσης